This program funds research proposals aimed at discovering new or repurposed therapies for neurofibromatosis (NF) and validating novel NF targets. Proposals should be concise and focused on generating key preliminary data to accelerate drug discovery progress.
Eligibility criteria are not specified for this funding opportunity.